The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Independent effect of polymeric nanoparticle zeta potential/surface charge, on their cytotoxicity and affinity to cells
Open accessAbstract
Objectives: Up to now, little research has been focussed on discovering how zeta potential independently affects polymeric nanoparticle (NP) cytotoxicity. Methods: Polymeric nanoparticles of gradient zeta potential ranging from −30 mv to +40 mv were fabricated using the same poly‐3‐hydroxybutyrate‐co‐3‐hydroxyhexanoate (PHBHH x) biopolymer. Interaction forces between nanoparticles and cells were measured by atomic force microscopy (AFM). Cytotoxicity of the nanoparticles to cells was investigated by using MTT (3‐(4,5‐dimethyl‐2‐thiazolyl)‐2,5‐diphenyl‐2‐H‐tetrazolium bromide) assay. Results: Four kinds of nanoparticle with similar sizes and gradient zeta potentials, were fabricated. Those with positive surface charges were found to be more toxic than those with negative surface charges. Positively charged nanoparticles or nanoparticles with higher ‘like’ charges, offered higher interaction force with cells. Conclusion: This work proposes a novel approach for investigating interaction between NP s and cells, and discloses the importance of controlling zeta potential in developing NP s‐based formulations in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biomolecular coronas provide the biological identity of nanosized materials
Monopoli, M. P., Åberg, C., Salvati, A., & Dawson, K. A. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.207 · Cited by 3,017
Lundqvist, M., Stigler, J., Elia, G., Lynch, I., Cedervall, T., & Dawson, K. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805135105 · Cited by 2,823
Lewinski, N., Colvin, V., & Drezek, R. (2008) · Small · doi:10.1002/smll.200700595 · Cited by 2,810
Salvati, A., Pitek, A. S., Monopoli, M. P., Prapainop, K., Bombelli, F. B., Hristov, D. R., Kelly, P. M., Åberg, C., Mahon, E., & Dawson, K. A. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2012.237 · Cited by 1,912
Monopoli, M. P., Walczyk, D., Campbell, A., Elia, G., Lynch, I., Baldelli Bombelli, F., & Dawson, K. A. (2011) · Journal of the American Chemical Society · doi:10.1021/ja107583h · Cited by 1,835
Carlson, C., Hussain, S. M., Schrand, A. M., K. Braydich-Stolle, L., Hess, K. L., Jones, R. L., & Schlager, J. J. (2008) · The Journal of Physical Chemistry B · doi:10.1021/jp712087m · Cited by 1,814
Toxicity of Gold Nanoparticles Functionalized with Cationic and Anionic Side Chains
Goodman, C. M., McCusker, C. D., Yilmaz, T., & Rotello, V. M. (2004) · Bioconjugate Chemistry · doi:10.1021/bc049951i · Cited by 1,601
Nanosuspensions in drug delivery
Rabinow, B. E. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1494 · Cited by 1,524
Sharifi, S., Behzadi, S., Laurent, S., Laird Forrest, M., Stroeve, P., & Mahmoudi, M. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15188f · Cited by 1,460
Lesniak, A., Fenaroli, F., Monopoli, M. P., Åberg, C., Dawson, K. A., & Salvati, A. (2012) · ACS Nano · doi:10.1021/nn300223w · Cited by 1,020
Physical and chemical stability of drug nanoparticles
Wu, L., Zhang, J., & Watanabe, W. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.02.001 · Cited by 993
Nanosuspensions: a promising drug delivery strategy
Patravale, V. B., Date, A. A., & Kulkarni, R. M. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357023691 · Cited by 904
Kulkarni, S. A., & Feng, S.-S. (2013) · Pharmaceutical Research · doi:10.1007/s11095-012-0958-3 · Cited by 768
Toxicology and clinical potential of nanoparticles
Yildirimer, L., Thanh, N. T. K., Loizidou, M., & Seifalian, A. M. (2011) · Nano Today · doi:10.1016/j.nantod.2011.10.001 · Cited by 676
Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine
Zhang, X.-Q., Xu, X., Bertrand, N., Pridgen, E., Swami, A., & Farokhzad, O. C. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.08.005 · Cited by 487
Wang, F., Yu, L., Monopoli, M. P., Sandin, P., Mahon, E., Salvati, A., & Dawson, K. A. (2013) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2013.04.010 · Cited by 427
Current Progress in Gene Delivery Technology Based on Chemical Methods and Nano-Carriers
Jin, L., Zeng, X., Liu, M., Deng, Y., & He, N. (2014) · Theranostics · doi:10.7150/thno.6914 · Cited by 388
Preformed albumin corona, a protective coating for nanoparticles based drug delivery system
Peng, Q., Zhang, S., Yang, Q., Zhang, T., Wei, X.-Q., Jiang, L., Zhang, C.-L., Chen, Q.-M., Zhang, Z.-R., & Lin, Y.-F. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.07.102 · Cited by 366
Self-citationMedical Application of Microbial Biopolyesters Polyhydroxyalkanoates
Wu, Q., Wang, Y., & Chen, G.-Q. (2009) · Artificial Cells, Blood Substitutes, and Biotechnology · doi:10.1080/10731190802664429 · Cited by 227
The transport mechanisms of polymer nanoparticles in Caco-2 epithelial cells
He, B., Lin, P., Jia, Z., Du, W., Qu, W., Yuan, L., Dai, W., Zhang, H., Wang, X., Wang, J., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.04.053 · Cited by 225
Polymer-Grafted Cellulose Nanocrystals as pH-Responsive Reversible Flocculants
Kan, K. H. M., Li, J., Wijesekera, K., & Cranston, E. D. (2013) · Biomacromolecules · doi:10.1021/bm400752k · Cited by 201
Time resolved study of cell death mechanisms induced by amine-modified polystyrene nanoparticles
Wang, F., Bexiga, M. G., Anguissola, S., Boya, P., Simpson, J. C., Salvati, A., & Dawson, K. A. (2013) · Nanoscale · doi:10.1039/c3nr03249c · Cited by 187
Strategies To Deliver Peptide Drugs to the Brain
Lalatsa, A., Schatzlein, A. G., & Uchegbu, I. F. (2014) · Molecular Pharmaceutics · doi:10.1021/mp400680d · Cited by 160
Peng, Q., Zhang, Z., Gong, T., Chen, G., & Sun, X. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.10.072 · Cited by 148
Self-citationPeng, Q., Sun, X., Gong, T., Wu, C., Zhang, T., Tan, J., & Zhang, Z.-R. (2012) · Acta Biomaterialia · doi:10.1016/j.actbio.2012.09.034 · Cited by 148
Self-citationAnguissola, S., Garry, D., Salvati, A. L., O'Brien, P. J., & Dawson, K. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108025 · Cited by 138
Core-Shell type lipid/rPAA-Chol polymer hybrid nanoparticles for in vivo siRNA delivery
Gao, L.-Y., Liu, X.-Y., Chen, C.-J., Wang, J.-C., Feng, Q., Yu, M.-Z., Ma, X.-F., Pei, X.-W., Niu, Y.-J., Qiu, C., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.11.046 · Cited by 114
PEGylated reduced graphene oxide as a superior ssRNA delivery system.
Zhang, L.-M., Wang, Z.-L., Lu, Z., Shen, H., Huang, J., Zhao, Q., Liu, M., He, N., & Zhang, Z. (2013) · Journal of materials chemistry. B · doi:10.1039/c2tb00096b · Cited by 100
Self-citationLow Dose of Amino-Modified Nanoparticles Induces Cell Cycle Arrest
Kim, J. A., Åberg, C., de Cárcer, G., Malumbres, M., Salvati, A. L., & Dawson, K. A. (2013) · ACS Nano · doi:10.1021/nn403126e · Cited by 95
Kim, J. A., Salvati, A. L., Åberg, C., & Dawson, K. A. (2014) · Nanoscale · doi:10.1039/c4nr04970e · Cited by 94
Mechanisms of Phospholipid Complex Loaded Nanoparticles Enhancing the Oral Bioavailability
Peng, Q., Zhang, Z., Sun, X., Zuo, J., Zhao, D. M., & Gong, T. (2010) · Molecular Pharmaceutics · doi:10.1021/mp900274u · Cited by 91
Self-citationChen, C.-J., Wang, J., Zhao, E.-Y., Gao, L., Feng, Q., Liu, X.-Y., Zhao, Z.-X., Ma, X., Hou, W., Zhang, L., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.03.056 · Cited by 90
Webb, W. R., Dale, T. P., Lomas, A. J., Zeng, G., Wimpenny, I., Haj, A. J. E., Forsyth, N. R., & Chen, G. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.05.041 · Cited by 89
Enhanced Biostability of Nanoparticle-Based Drug Delivery Systems by Albumin Corona
Peng, Q., Wei, X., Yang, Q., Zhang, S., Zhang, T., Shao, X., Cai, X., Zhang, Z., & Lin, Y. (2015) · Nanomedicine · doi:10.2217/nnm.14.86 · Cited by 85
Self-citationSaxena, R. K., Williams, W. C., McGee, J. K., Daniels, M. J., Boykin, E. H., & Gilmour, M. I. (2007) · Nanotoxicology · doi:10.1080/17435390701803110 · Cited by 81
Guiding Principles in The Design of Ligand-Targeted Nanomedicines
Wang, X., Galliford, C. V., & Low, P. S. (2014) · Nanomedicine · doi:10.2217/nnm.13.175 · Cited by 63
Zhang, L., Lu, Z., Li, X., Deng, Y., Zhang, F., Ma, C., & He, N. (2012) · Polymer Chemistry · doi:10.1039/c2py20201h · Cited by 48
Lomas, A. J., Webb, W. R., Han, J., Chen, G., Sun, X., Zhang, Z., Haj, A. J. E., & Forsyth, N. R. (2013) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2012.0457 · Cited by 46
Self-citationSoenen, S. J., Manshian, B. B., Doak, S. H., Smedt, S. C. D., & Braeckmans, K. (2013) · Acta Biomaterialia · doi:10.1016/j.actbio.2013.04.026 · Cited by 42
New Low Molecular Weight Polycation-Based Nanoparticles for Effective Codelivery of pDNA and Drug
Zhao, Y., Yu, B., Hu, H., Hu, Y., Zhao, N., & Xu, F. (2014) · ACS Applied Materials & Interfaces · doi:10.1021/am5046179 · Cited by 38
Nanocomplex Based on Biocompatible Phospholipids and Albumin for Long-Circulation Applications
Peng, Q., Wei, X., Shao, X., Zhang, T., Zhang, S., Fu, N., Cai, X., Zhang, Z., & Lin, Y. (2014) · ACS Applied Materials & Interfaces · doi:10.1021/am503179a · Cited by 36
Self-citationSynthesis, Colloidal Properties and Cytotoxicity of Biopolymer Nanoparticles
Moorkoth, D., & Nampoothiri, K. M. (2014) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-014-1172-z · Cited by 21
Peng, Q., Yang, Y., Zhang, T., Wu, C., Yang, Q., Sun, X., Gong, T., Zhang, L., & Zhang, Z. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0944-9 · Cited by 16
Self-citationPositive Charge, Negative Effect: The Impact of Cationic Nanoparticles in The Brain
M�ller, P., & Lykkesfeldt, J. (2014) · Nanomedicine · doi:10.2217/nnm.14.91 · Cited by 7
Cited by
Risk assessment of microplastic particles
Koelmans, A. A., Redondo-Hasselerharm, P. E., Nor, N. H. M., de Ruijter, V. N., Mintenig, S. M., & Kooi, M. (2022) · Nature Reviews Materials · doi:10.1038/s41578-021-00411-y · Cited by 1,140
Biodegradable Polymeric Nanoparticles for Drug Delivery to Solid Tumors
Gagliardi, A., Giuliano, E., Venkateswararao, E., Fresta, M., Bulotta, S., Awasthi, V., & Cosco, D. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.601626 · Cited by 571
Effects of nanoparticle size, shape, and zeta potential on drug delivery
Öztürk, K., Kaplan, M., & Çalış, S. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124799 · Cited by 449
Exosomes: The next generation of endogenous nanomaterials for advanced drug delivery and therapy
Liao, W., Du, Y., Zhang, C., Pan, F., Yao, Y., Zhang, T., & Peng, Q. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.12.045 · Cited by 411
Self-citationScale-up polymeric-based nanoparticles drug delivery systems: Development and challenges
Herdiana, Y., Wathoni, N., Shamsuddin, S., & Muchtaridi, M. (2022) · OpenNano · doi:10.1016/j.onano.2022.100048 · Cited by 329
Metadata
- Authors
- Shao, X., Wei, X., Song, X., Hao, L., Cai, X., Zhang, Z., Peng, Q., & Lin, Y.
- Venue
- Cell Proliferation
- Publisher
- Wiley
- Published
- 2015-05-27
- Volume
- 48
- Issue
- 4
- Pages
- 465-474
- ISSN
- 0960-7722 (ISSN-L)
- 1365-2184
- OpenAlex
- W1605008923
- Cited by
- 310
- References
- 44
- FWCI
- 2.59
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.